ABBOTT M2000SP
Report
- Report Number
- 3005248192-2014-00083
- Event Type
- Malfunction
- Date Received
- December 12, 2014
- Date of Event
- November 17, 2014
- Report Date
- November 17, 2014
- Manufacturer
- ABBOTT MOLECULAR, INC.
- Product Code
- JJH
- PMA / PMN Number
- K092705
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- MO
- Reporter Occupation
- OTHER
Narratives
SUMMARY OF ELEVATED COMPLAINT INVESTIGATION (B)(4): PROBLEM: EXCESSIVE NOISE FROM THE LIHA AND ROMA X-DRIVE MOTORS WAS REPORTED. NOISE AND STEP-LOSS FAILURES OCCUR WITHIN 2-3 MONTHS OF INSTRUMENT INSTALLATION OR REPLACEMENT SPARE PART INSTALLATION. CONCLUSIONS: RETAIN TESTING OF THE X-DRIVE MOTOR WAS NOT APPLICABLE AS NO FILE SAMPLES ARE RETAINED. SUPPLIER TECAN HAS CONFIRMED A PRODUCT DEFICIENCY WITH THE DRIVE BELT PRODUCTION PROCESS ON SOME BELTS. WITHIN 2-3 MONTHS OF OPERATION THE BELT TENSION CHANGES LEADING TO EXCESSIVE NOISE AND IN SOME CASES THE ASSOCIATED ARM CRASHES INTO A WORKTABLE OBJECT OR BECOMES MISALIGNED. X-DRIVE AXIS MOTOR REPLACEMENT SPARE PARTS AND ALL M2000SP AND M24SP INSTRUMENTS MANUFACTURED WITH THE ASSEMBLIES WITH DATE CODES BETWEEN 01 JANUARY 2013 THROUGH 30 SEPTEMBER 2013 ARE SUSPECT. THE M2000SP SERVICE MANUAL CONTAINS ADEQUATE INSTRUCTIONS FOR TROUBLESHOOTING X-DRIVE MOTOR ISSUES WITH REPLACEMENT INSTRUCTIONS AND PART NUMBER INFORMATION. VALID MATERIAL SPECIFICATIONS ARE RESIDENT IN PILGRIM SMARTSOLVE FOR THE MOTOR DC ARM X-AXIS 1000 INCREMENTS EVO PART NUMBER 10649045. A THOROUGH COMPLAINT SEARCH WAS PERFORMED TO IDENTIFY PAST COMPLAINT TICKETS FROM THE LAST TWO YEARS FOR ANY INSTANCES OF THE X-DRIVE MOTORS MAKING EXCESSIVE NOISE ON THE M2000SP INSTRUMENT. (B)(4). ABBOTT MOLECULAR DETERMINED A FIELD ACTION (CORRECTION) SHOULD BE TAKEN TO INSPECT AND, IF NECESSARY, REPLACE THE AFFECTED BELTS. ABBOTT MOLECULAR INITIATED FIELD ACTION NUMBER FA-CAM-NOV2013-177 ON NOVEMBER 23, 2013 AS A RECORDABLE FIELD ACTION. UPON RECEIPT OF FDA 483 OBSERVATION #1 ON JULY 11, 2014, ABBOTT MOLECULAR DETERMINED THIS FIELD ACTION SHOULD HAVE BEEN REPORTED TO FDA PER 21 CFR 806, AND ON JULY 29, 2014 REPORTED IT TO THE FDA (B)(4) DISRICT RECALL COORDINATOR. THEREFORE, THE PURPOSE OF SUBMITTING MDR 3005248192-2014-00083 IS TO REPORT THIS COMPLAINT BECAUSE IT IS ASSOCIATED WITH REPORTABLE FIELD ACTION FA-CAM-NOV2013-177 (806 REPORT NUMBER 3005248192-07/28/2014-002-C). TO DATE, AN FDA RECALL NUMBER HAS NOT BEEN RECEIVED. THE FOLLOWING MDRS WERE ALSO REPORTED: MDR 3005248192-2014-00007, MDR 3005248192-2014-00008, MDR 3005248192-2014-00009, MDR 3005248192-2014-00010, MDR 3005248192-2014-00011, MDR 3005248192-2014-00012, MDR 3005248192-2014-00013, MDR 3005248192-2014-00014, MDR 3005248192-2014-00015, MDR 3005248192-2014-00016, MDR 3005248192-2014-00017, MDR 3005248192-2014-00018, MDR 3005248192-2014-00019, MDR 3005248192-2014-00020, MDR 3005248192-2014-00021, MDR 3005248192-2014-00022, MDR 3005248192-2014-00023, MDR 3005248192-2014-00024, MDR 3005248192-2014-00025, MDR 3005248192-2014-00026, MDR 3005248192-2014-00027, MDR 3005248192-2014-00028, MDR 3005248192-2014-00029, MDR 3005248192-2014-00030, MDR 3005248192-2014-00031, MDR 3005248192-2014-00032, MDR 3005248192-2014-00033, MDR 3005248192-2014-00034, MDR 3005248192-2014-00035, MDR 3005248192-2014-00036, MDR 3005248192-2014-00037, MDR 3005248192-2014-00038, MDR 3005248192-2014-00039, MDR 3005248192-2014-00040, MDR 3005248192-2014-00041, MDR 3005248192-2014-00042, MDR 3005248192-2014-00043, MDR 3005248192-2014-00044, MDR 3005248192-2014-00045, MDR 3005248192-2014-00046, MDR 3005248192-2014-00047, MDR 3005248192-2014-00048, MDR 3005248192-2014-00049, MDR 3005248192-2014-00050, MDR 3005248192-2014-00051, MDR 3005248192-2014-00052, MDR 3005248192-2014-00053, MDR 3005248192-2014-00054, MDR 3005248192-2014-00055, MDR 3005248192-2014-00058, MDR 3005248192-2014-00059, MDR 3005248192-2014-00060, MDR 3005248192-2014-00063, MDR 3005248192-2014-00064, MDR 3005248192-2014-00065, MDR 3005248192-2014-00071, MDR 3005248192-2014-00072 MDR 3005248192-2014-00076, MDR 3005248192-2014-00077, MDR 3005248192-2014-00078, MDR 3005248192-2014-00079, MDR 3005248192-2014-00080, MDR 3005248192-2014-00081, MDR 3005248192-2014-00082.
THE ABBOTT M2000 SYSTEM IS INTENDED FOR USE IN PERFORMING NUCLEIC ACID AMPLIFICATION TESTING BY POLYMERASE CHAIN REACTION IN CLINICAL LABORATORIES. THE SYSTEM IS COMPOSED OF THE M2000RT AND THE M2000SP INSTRUMENTS. THE M2000SP IS INTENDED FOR AUTOMATED SAMPLE PREPARATION AND NUCLEIC ACID EXTRACTION PRIOR TO TESTING. THE LIQUID HANDLING ARM (LIHA) IS A MECHANICAL COMPONENT OF THE M2000SP INSTRUMENT THAT PIPETTES AND DISPENSES SAMPLES AND REAGENTS. THE ROBOTIC MANIPULATOR ARM (ROMA) IS A MECHANICAL COMPONENT OF THE M2000SP INSTRUMENT THAT MOVES THE DISPOSABLE TIP RACKS TO DIFFERENT POSITIONS ON THE WORKTABLE. A FIELD SERVICE ENGINEER (FSE) VISITED THE CUSTOMER SITE TO PERFORM TECHNICAL SERVICE BULLETIN (TSB) 606-041 "M2000SP X-DRIVE ASSEMBLY BELT INSPECTION AND REPLACEMENT PROCEDURE". THE FSE DETERMINED THAT THE ROMA X-BELT FAILED THE INSPECTION CRITERIA DUE TO SIGNS OF CORROSION. THE ROMA BELT WAS REPLACED PER TSB 606-041. THE LIHA BELT PASSED THE INSPECTION CRITERIA AND DID NOT NEED REPLACEMENT. THERE WAS NOT ANY REPORT OF INJURY. MEDICAL EVALUATION CONCLUDED THIS ISSUE IS NOT LIKELY TO CAUSE OR CONTRIBUTE TO DEATH OR SERIOUS INJURY. THIS COMPLAINT IS REPORTED IN ACCORDANCE WITH 21 CFR 803 ON THE BASIS IT IS LINKED TO REPORTABLE FIELD ACTION FA-CAM-NOV2013-177, PER 21 CFR 806. (B)(4).
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 809369 | ABBOTT M2000SP | CLINICAL SAMPLE CONCENTRATOR | JJH | ABBOTT MOLECULAR, INC. |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 |